Newsbenzinga
Crescent Biopharma Says Initial Data From Phase 1/2 CR-001 Trial On Track For Q1 2027; Sees Potential Phase 3 Start In Early 2028
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…